img

Global Pediatric Orphan Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Pediatric Orphan Drugs Market Insights, Forecast to 2034

Pediatric orphan drugs are medications that are specifically developed and approved for the treatment of rare diseases or conditions in children. These drugs are designed to address medical needs in pediatric populations who have limited treatment options due to the rarity of their conditions. Pediatric orphan drugs are vital in addressing the unique medical needs of children with rare diseases and improving their health outcomes and quality of life.
Market Analysis and InsightsGlobal Pediatric Orphan Drugs Market
Global Pediatric Orphan Drugs market is expected to reach to US$ 56130 million in 2023, with a positive growth of %, compared with US$ 51490 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Pediatric Orphan Drugs industry is evaluated to reach US$ 102180 million in 2033. The CAGR will be 10.5% during 2023 to 2033.
According to our “ Pharma & Healthcare Research Center” statistics, the global sales of Orphan Drugs reached $139170 million in 2022. The North America region was the world largest Orphan Drugs market, accounting for 40% of Orphan Drugs sales in 2022, followed by Asia-Pacific. The global market for pediatric orphan drugs has been growing steadily in recent years due to increasing awareness of rare pediatric diseases, advancements in medical research and technology, and improved regulatory support for pediatric drug development.
Report Covers
This report presents an overview of global Pediatric Orphan Drugs market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Pediatric Orphan Drugs market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Recordati SpA
Novartis
Celgene
Abbvie
Orpharma
Amgen
Amryt Pharma Plc.
Johnson & Johnson
GSK
Bristol-Myers Squibb Company
Roche Holding
Pfizer
Sanofi
Takeda
Segment by Type
Oncology Drugs
Gastrointestinal Drugs
Neurology Drugs
Cardio-vascular Drugs
Others

Segment by Application


Hospital Pharmacies
Retail pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Pediatric Orphan Drugs introduction, etc. Pediatric Orphan Drugs Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Pediatric Orphan Drugs
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Orphan Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Oncology Drugs
1.2.3 Gastrointestinal Drugs
1.2.4 Neurology Drugs
1.2.5 Cardio-vascular Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Pediatric Orphan Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail pharmacies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Orphan Drugs Market Perspective (2018-2033)
2.2 Global Pediatric Orphan Drugs Growth Trends by Region
2.2.1 Pediatric Orphan Drugs Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Pediatric Orphan Drugs Historic Market Size by Region (2018-2023)
2.2.3 Pediatric Orphan Drugs Forecasted Market Size by Region (2024-2033)
2.3 Pediatric Orphan Drugs Market Dynamics
2.3.1 Pediatric Orphan Drugs Industry Trends
2.3.2 Pediatric Orphan Drugs Market Drivers
2.3.3 Pediatric Orphan Drugs Market Challenges
2.3.4 Pediatric Orphan Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pediatric Orphan Drugs by Players
3.1.1 Global Pediatric Orphan Drugs Revenue by Players (2018-2023)
3.1.2 Global Pediatric Orphan Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Pediatric Orphan Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pediatric Orphan Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Pediatric Orphan Drugs Market Concentration Ratio
3.4.1 Global Pediatric Orphan Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Orphan Drugs Revenue in 2022
3.5 Global Key Players of Pediatric Orphan Drugs Head office and Area Served
3.6 Global Key Players of Pediatric Orphan Drugs, Product and Application
3.7 Global Key Players of Pediatric Orphan Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Orphan Drugs Breakdown Data by Type
4.1 Global Pediatric Orphan Drugs Historic Market Size by Type (2018-2023)
4.2 Global Pediatric Orphan Drugs Forecasted Market Size by Type (2024-2033)
5 Pediatric Orphan Drugs Breakdown Data by Application
5.1 Global Pediatric Orphan Drugs Historic Market Size by Application (2018-2023)
5.2 Global Pediatric Orphan Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Pediatric Orphan Drugs Market Size (2018-2033)
6.2 North America Pediatric Orphan Drugs Market Size by Type
6.2.1 North America Pediatric Orphan Drugs Market Size by Type (2018-2023)
6.2.2 North America Pediatric Orphan Drugs Market Size by Type (2024-2033)
6.2.3 North America Pediatric Orphan Drugs Market Share by Type (2018-2033)
6.3 North America Pediatric Orphan Drugs Market Size by Application
6.3.1 North America Pediatric Orphan Drugs Market Size by Application (2018-2023)
6.3.2 North America Pediatric Orphan Drugs Market Size by Application (2024-2033)
6.3.3 North America Pediatric Orphan Drugs Market Share by Application (2018-2033)
6.4 North America Pediatric Orphan Drugs Market Size by Country
6.4.1 North America Pediatric Orphan Drugs Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Pediatric Orphan Drugs Market Size by Country (2018-2023)
6.4.3 North America Pediatric Orphan Drugs Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Pediatric Orphan Drugs Market Size (2018-2033)
7.2 Europe Pediatric Orphan Drugs Market Size by Type
7.2.1 Europe Pediatric Orphan Drugs Market Size by Type (2018-2023)
7.2.2 Europe Pediatric Orphan Drugs Market Size by Type (2024-2033)
7.2.3 Europe Pediatric Orphan Drugs Market Share by Type (2018-2033)
7.3 Europe Pediatric Orphan Drugs Market Size by Application
7.3.1 Europe Pediatric Orphan Drugs Market Size by Application (2018-2023)
7.3.2 Europe Pediatric Orphan Drugs Market Size by Application (2024-2033)
7.3.3 Europe Pediatric Orphan Drugs Market Share by Application (2018-2033)
7.4 Europe Pediatric Orphan Drugs Market Size by Country
7.4.1 Europe Pediatric Orphan Drugs Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Pediatric Orphan Drugs Market Size by Country (2018-2023)
7.4.3 Europe Pediatric Orphan Drugs Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Pediatric Orphan Drugs Market Size (2018-2033)
8.2 China Pediatric Orphan Drugs Market Size by Type
8.2.1 China Pediatric Orphan Drugs Market Size by Type (2018-2023)
8.2.2 China Pediatric Orphan Drugs Market Size by Type (2024-2033)
8.2.3 China Pediatric Orphan Drugs Market Share by Type (2018-2033)
8.3 China Pediatric Orphan Drugs Market Size by Application
8.3.1 China Pediatric Orphan Drugs Market Size by Application (2018-2023)
8.3.2 China Pediatric Orphan Drugs Market Size by Application (2024-2033)
8.3.3 China Pediatric Orphan Drugs Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Pediatric Orphan Drugs Market Size (2018-2033)
9.2 Asia Pediatric Orphan Drugs Market Size by Type
9.2.1 Asia Pediatric Orphan Drugs Market Size by Type (2018-2023)
9.2.2 Asia Pediatric Orphan Drugs Market Size by Type (2024-2033)
9.2.3 Asia Pediatric Orphan Drugs Market Share by Type (2018-2033)
9.3 Asia Pediatric Orphan Drugs Market Size by Application
9.3.1 Asia Pediatric Orphan Drugs Market Size by Application (2018-2023)
9.3.2 Asia Pediatric Orphan Drugs Market Size by Application (2024-2033)
9.3.3 Asia Pediatric Orphan Drugs Market Share by Application (2018-2033)
9.4 Asia Pediatric Orphan Drugs Market Size by Region
9.4.1 Asia Pediatric Orphan Drugs Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Pediatric Orphan Drugs Market Size by Region (2018-2023)
9.4.3 Asia Pediatric Orphan Drugs Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Recordati SpA
11.1.1 Recordati SpA Company Details
11.1.2 Recordati SpA Business Overview
11.1.3 Recordati SpA Pediatric Orphan Drugs Introduction
11.1.4 Recordati SpA Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.1.5 Recordati SpA Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Pediatric Orphan Drugs Introduction
11.2.4 Novartis Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.2.5 Novartis Recent Developments
11.3 Celgene
11.3.1 Celgene Company Details
11.3.2 Celgene Business Overview
11.3.3 Celgene Pediatric Orphan Drugs Introduction
11.3.4 Celgene Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.3.5 Celgene Recent Developments
11.4 Abbvie
11.4.1 Abbvie Company Details
11.4.2 Abbvie Business Overview
11.4.3 Abbvie Pediatric Orphan Drugs Introduction
11.4.4 Abbvie Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.4.5 Abbvie Recent Developments
11.5 Orpharma
11.5.1 Orpharma Company Details
11.5.2 Orpharma Business Overview
11.5.3 Orpharma Pediatric Orphan Drugs Introduction
11.5.4 Orpharma Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.5.5 Orpharma Recent Developments
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Pediatric Orphan Drugs Introduction
11.6.4 Amgen Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.6.5 Amgen Recent Developments
11.7 Amryt Pharma Plc.
11.7.1 Amryt Pharma Plc. Company Details
11.7.2 Amryt Pharma Plc. Business Overview
11.7.3 Amryt Pharma Plc. Pediatric Orphan Drugs Introduction
11.7.4 Amryt Pharma Plc. Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.7.5 Amryt Pharma Plc. Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Pediatric Orphan Drugs Introduction
11.8.4 Johnson & Johnson Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.8.5 Johnson & Johnson Recent Developments
11.9 GSK
11.9.1 GSK Company Details
11.9.2 GSK Business Overview
11.9.3 GSK Pediatric Orphan Drugs Introduction
11.9.4 GSK Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.9.5 GSK Recent Developments
11.10 Bristol-Myers Squibb Company
11.10.1 Bristol-Myers Squibb Company Company Details
11.10.2 Bristol-Myers Squibb Company Business Overview
11.10.3 Bristol-Myers Squibb Company Pediatric Orphan Drugs Introduction
11.10.4 Bristol-Myers Squibb Company Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.10.5 Bristol-Myers Squibb Company Recent Developments
11.11 Roche Holding
11.11.1 Roche Holding Company Details
11.11.2 Roche Holding Business Overview
11.11.3 Roche Holding Pediatric Orphan Drugs Introduction
11.11.4 Roche Holding Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.11.5 Roche Holding Recent Developments
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Pediatric Orphan Drugs Introduction
11.12.4 Pfizer Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.12.5 Pfizer Recent Developments
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Pediatric Orphan Drugs Introduction
11.13.4 Sanofi Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.13.5 Sanofi Recent Developments
11.14 Takeda
11.14.1 Takeda Company Details
11.14.2 Takeda Business Overview
11.14.3 Takeda Pediatric Orphan Drugs Introduction
11.14.4 Takeda Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.14.5 Takeda Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pediatric Orphan Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Oncology Drugs
Table 3. Key Players of Gastrointestinal Drugs
Table 4. Key Players of Neurology Drugs
Table 5. Key Players of Cardio-vascular Drugs
Table 6. Key Players of Others
Table 7. Global Pediatric Orphan Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Pediatric Orphan Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Pediatric Orphan Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Pediatric Orphan Drugs Market Share by Region (2018-2023)
Table 11. Global Pediatric Orphan Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Pediatric Orphan Drugs Market Share by Region (2024-2033)
Table 13. Pediatric Orphan Drugs Market Trends
Table 14. Pediatric Orphan Drugs Market Drivers
Table 15. Pediatric Orphan Drugs Market Challenges
Table 16. Pediatric Orphan Drugs Market Restraints
Table 17. Global Pediatric Orphan Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Pediatric Orphan Drugs Revenue Share by Players (2018-2023)
Table 19. Global Top Pediatric Orphan Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Orphan Drugs as of 2022)
Table 20. Global Pediatric Orphan Drugs Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Pediatric Orphan Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Pediatric Orphan Drugs, Headquarters and Area Served
Table 23. Global Key Players of Pediatric Orphan Drugs, Product and Application
Table 24. Global Key Players of Pediatric Orphan Drugs, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pediatric Orphan Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Pediatric Orphan Drugs Revenue Market Share by Type (2018-2023)
Table 28. Global Pediatric Orphan Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Pediatric Orphan Drugs Revenue Market Share by Type (2024-2033)
Table 30. Global Pediatric Orphan Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Pediatric Orphan Drugs Revenue Share by Application (2018-2023)
Table 32. Global Pediatric Orphan Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Pediatric Orphan Drugs Revenue Share by Application (2024-2033)
Table 34. North America Pediatric Orphan Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Pediatric Orphan Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Pediatric Orphan Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Pediatric Orphan Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Pediatric Orphan Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Pediatric Orphan Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Pediatric Orphan Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Pediatric Orphan Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Pediatric Orphan Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Pediatric Orphan Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Pediatric Orphan Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Pediatric Orphan Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Pediatric Orphan Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Pediatric Orphan Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Pediatric Orphan Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Pediatric Orphan Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Pediatric Orphan Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Pediatric Orphan Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Pediatric Orphan Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Pediatric Orphan Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Pediatric Orphan Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Pediatric Orphan Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Pediatric Orphan Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Pediatric Orphan Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 66. Recordati SpA Company Details
Table 67. Recordati SpA Business Overview
Table 68. Recordati SpA Pediatric Orphan Drugs Product
Table 69. Recordati SpA Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 70. Recordati SpA Recent Developments
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Pediatric Orphan Drugs Product
Table 74. Novartis Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 75. Novartis Recent Developments
Table 76. Celgene Company Details
Table 77. Celgene Business Overview
Table 78. Celgene Pediatric Orphan Drugs Product
Table 79. Celgene Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 80. Celgene Recent Developments
Table 81. Abbvie Company Details
Table 82. Abbvie Business Overview
Table 83. Abbvie Pediatric Orphan Drugs Product
Table 84. Abbvie Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 85. Abbvie Recent Developments
Table 86. Orpharma Company Details
Table 87. Orpharma Business Overview
Table 88. Orpharma Pediatric Orphan Drugs Product
Table 89. Orpharma Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 90. Orpharma Recent Developments
Table 91. Amgen Company Details
Table 92. Amgen Business Overview
Table 93. Amgen Pediatric Orphan Drugs Product
Table 94. Amgen Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 95. Amgen Recent Developments
Table 96. Amryt Pharma Plc. Company Details
Table 97. Amryt Pharma Plc. Business Overview
Table 98. Amryt Pharma Plc. Pediatric Orphan Drugs Product
Table 99. Amryt Pharma Plc. Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 100. Amryt Pharma Plc. Recent Developments
Table 101. Johnson & Johnson Company Details
Table 102. Johnson & Johnson Business Overview
Table 103. Johnson & Johnson Pediatric Orphan Drugs Product
Table 104. Johnson & Johnson Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 105. Johnson & Johnson Recent Developments
Table 106. GSK Company Details
Table 107. GSK Business Overview
Table 108. GSK Pediatric Orphan Drugs Product
Table 109. GSK Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 110. GSK Recent Developments
Table 111. Bristol-Myers Squibb Company Company Details
Table 112. Bristol-Myers Squibb Company Business Overview
Table 113. Bristol-Myers Squibb Company Pediatric Orphan Drugs Product
Table 114. Bristol-Myers Squibb Company Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 115. Bristol-Myers Squibb Company Recent Developments
Table 116. Roche Holding Company Details
Table 117. Roche Holding Business Overview
Table 118. Roche Holding Pediatric Orphan Drugs Product
Table 119. Roche Holding Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 120. Roche Holding Recent Developments
Table 121. Pfizer Company Details
Table 122. Pfizer Business Overview
Table 123. Pfizer Pediatric Orphan Drugs Product
Table 124. Pfizer Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 125. Pfizer Recent Developments
Table 126. Sanofi Company Details
Table 127. Sanofi Business Overview
Table 128. Sanofi Pediatric Orphan Drugs Product
Table 129. Sanofi Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 130. Sanofi Recent Developments
Table 131. Takeda Company Details
Table 132. Takeda Business Overview
Table 133. Takeda Pediatric Orphan Drugs Product
Table 134. Takeda Revenue in Pediatric Orphan Drugs Business (2018-2023) & (US$ Million)
Table 135. Takeda Recent Developments
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Orphan Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Pediatric Orphan Drugs Market Share by Type: 2022 VS 2033
Figure 3. Oncology Drugs Features
Figure 4. Gastrointestinal Drugs Features
Figure 5. Neurology Drugs Features
Figure 6. Cardio-vascular Drugs Features
Figure 7. Others Features
Figure 8. Global Pediatric Orphan Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Pediatric Orphan Drugs Market Share by Application: 2022 VS 2033
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail pharmacies Case Studies
Figure 12. Others Case Studies
Figure 13. Pediatric Orphan Drugs Report Years Considered
Figure 14. Global Pediatric Orphan Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Pediatric Orphan Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Pediatric Orphan Drugs Market Share by Region: 2022 VS 2033
Figure 17. Global Pediatric Orphan Drugs Market Share by Players in 2022
Figure 18. Global Top Pediatric Orphan Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Orphan Drugs as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Pediatric Orphan Drugs Revenue in 2022
Figure 20. North America Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Pediatric Orphan Drugs Market Share by Type (2018-2033)
Figure 22. North America Pediatric Orphan Drugs Market Share by Application (2018-2033)
Figure 23. North America Pediatric Orphan Drugs Market Share by Country (2018-2033)
Figure 24. United States Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Pediatric Orphan Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe Pediatric Orphan Drugs Market Share by Type (2018-2033)
Figure 28. Europe Pediatric Orphan Drugs Market Share by Application (2018-2033)
Figure 29. Europe Pediatric Orphan Drugs Market Share by Country (2018-2033)
Figure 30. Germany Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China Pediatric Orphan Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China Pediatric Orphan Drugs Market Share by Type (2018-2033)
Figure 38. China Pediatric Orphan Drugs Market Share by Application (2018-2033)
Figure 39. Asia Pediatric Orphan Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia Pediatric Orphan Drugs Market Share by Type (2018-2033)
Figure 41. Asia Pediatric Orphan Drugs Market Share by Application (2018-2033)
Figure 42. Asia Pediatric Orphan Drugs Market Share by Region (2018-2033)
Figure 43. Japan Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America Pediatric Orphan Drugs Market Share by Country (2018-2033)
Figure 53. Brazil Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries Pediatric Orphan Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Recordati SpA Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 60. Novartis Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 61. Celgene Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 62. Abbvie Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 63. Orpharma Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 64. Amgen Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 65. Amryt Pharma Plc. Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 66. Johnson & Johnson Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 67. GSK Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 68. Bristol-Myers Squibb Company Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 69. Roche Holding Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 70. Pfizer Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 71. Sanofi Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 72. Takeda Revenue Growth Rate in Pediatric Orphan Drugs Business (2018-2023)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries